2026-2034年全球獸醫腫瘤市場規模、佔有率、趨勢和成長分析報告

全球獸醫腫瘤市場預計將從2025年的8.4億美元成長至2034年的23.8億美元，2026年至2034年的複合年成長率（CAGR）為12.22%。寵物健康意識的提高和動物癌症發生率的上升是推動獸醫腫瘤市場強勁成長的主要因素。隨著寵物飼主越來越希望為他們心愛的寵物尋求更先進的治療方案，對獸醫腫瘤服務和產品的需求也不斷成長。人們對寵物健康的日益關注，以及獸醫學的進步，正在推動用於治療動物癌症的創新療法和診斷工具的研發。隨著獸醫院將癌症患者的專科護理列為優先事項，獸醫腫瘤市場預計將進一步發展。

技術進步在塑造獸醫腫瘤市場的未來方面發揮著至關重要的作用。磁振造影（MRI）和電腦斷層掃描）等影像技術的創新提高了寵物腫瘤的檢測和後續觀察能力，從而實現了更早期、更準確的診斷。此外，標靶治療和免疫療法的開發正在革新獸醫癌症治療，為寵物飼主提供更有效、創傷更小的治療選擇。隨著製造商和獸醫專業人士在研發領域的持續合作，預計獸醫腫瘤市場將進一步採用先進的治療方法和技術。

此外，寵物護理領域對個人化醫療和整體療法的日益重視也影響著獸醫腫瘤市場。隨著寵物飼主對寵物健康了解的不斷深入，他們對能夠充分考慮​​每位患者個別需求和意願的客製化治療方案的需求也日益成長。這一趨勢推動了綜合腫瘤服務的發展，將傳統療法與營養管理和疼痛管理等輔助療法相結合。隨著市場的不斷發展，技術、個人化護理和整體療法的融合將成為獸醫腫瘤領域成功的關鍵驅動力。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球獸醫腫瘤市場：依動物類型分類

• 市場分析、洞察與預測
• 伴侶動物（馬、狗、貓）
• 家畜

第5章：全球獸醫腫瘤市場：依治療類型分類

• 市場分析、洞察與預測
• 化療
• 聯合治療
• 免疫療法
• 標靶治療

第6章：全球獸醫腫瘤市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 靜脈

第7章：全球獸醫腫瘤市場：依應用分類

• 市場分析、洞察與預測
• 犬淋巴瘤
• 骨癌（OSA）
• 肥大細胞癌
• 黑色素瘤
• 其他

第8章：全球獸醫腫瘤市場：依通路分類

• 市場分析、洞察與預測
• 醫院藥房
• 政府機構
• 零售藥房

第9章 全球獸醫腫瘤市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Zoetis
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Merck Animal Health
  • Virbac
  • Dechra Pharmaceuticals
  • Ceva Sante Animale
  • IDEXX Laboratories
  • Antech Diagnostics
  • PetCure Oncology
  • Ethos Veterinary Health
  • BluePearl Pet Hospital
  • Mars Veterinary Health
  • Animal Oncology And Imaging Center
  • Varian
  • Accuray
  • Elekta
  • VetDC
  • Anivive Lifesciences
  • One Health Group

The global veterinary oncology market size is expected to reach USD 2.38 Billion in 2034 from USD 0.84 Billion in 2025, growing at a CAGR of 12.22% during 2026-2034.The Veterinary Oncology Market is experiencing robust growth as the awareness of pet health and the prevalence of cancer in animals continue to rise. As pet owners increasingly seek advanced treatment options for their beloved companions, the demand for veterinary oncology services and products is expanding. The growing focus on pet wellness, coupled with advancements in veterinary medicine, is driving the development of innovative therapies and diagnostic tools for cancer treatment in animals. As veterinary practices prioritize specialized care for oncology patients, the market for veterinary oncology is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the veterinary oncology market. Innovations in diagnostic imaging, such as MRI and CT scans, are enhancing the ability to detect and monitor tumors in pets, leading to earlier and more accurate diagnoses. Additionally, the development of targeted therapies and immunotherapies is revolutionizing cancer treatment in veterinary medicine, offering more effective and less invasive options for pet owners. As manufacturers and veterinary professionals continue to collaborate on research and development, the veterinary oncology market is likely to see increased adoption of advanced treatment modalities and technologies.

Moreover, the growing emphasis on personalized medicine and holistic approaches to pet care is influencing the veterinary oncology market. As pet owners become more informed about their pets' health, there is a rising demand for tailored treatment plans that consider individual patient needs and preferences. This trend is driving the development of integrative oncology services that combine conventional treatments with complementary therapies, such as nutrition and pain management. As the market continues to evolve, the integration of technology, personalized care, and holistic approaches will be key drivers of success in the veterinary oncology sector.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Animal Type

• Companion Animal (Equine, Canine, and Feline)
• Livestock Animal

By Therapy Type

• Chemotherapy
• Combination Therapy
• Immunotherapy
• Targeted Therapy

By Mode of Administration

• Oral
• Intravenous

By Application

• Canine Lymphoma
• Osteosarcoma (OSA)
• Mast Cell Cancer
• Melanoma
• Others

By Distribution Channel

• Hospital Pharmacies
• Government Agencies
• Retail Pharmacies

COMPANIES PROFILED

• Zoetis, Boehringer Ingelheim Animal Health, Elanco Animal Health, Merck Animal Health, Virbac, Dechra Pharmaceuticals, Ceva Sante Animale, IDEXX Laboratories, Antech Diagnostics, PetCure Oncology, Ethos Veterinary Health, BluePearl Pet Hospital, Mars Veterinary Health, Animal Oncology and Imaging Center, Varian, Accuray, Elekta, VetDC, Anivive Lifesciences, One Health Group

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY ONCOLOGY MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal Type
• 4.2. Companion Animal (Equine, Canine, and Feline) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Livestock Animal Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY ONCOLOGY MARKET: BY THERAPY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy Type
• 5.2. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Combination Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Targeted Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY ONCOLOGY MARKET: BY MODE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Intravenous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY ONCOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Canine Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Osteosarcoma (OSA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Mast Cell Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Melanoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY ONCOLOGY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Distribution Channel
• 8.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Government Agencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY ONCOLOGY MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Animal Type
  • 9.2.2 By Therapy Type
  • 9.2.3 By Mode Of Administration
  • 9.2.4 By Application
  • 9.2.5 By Distribution Channel
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Animal Type
  • 9.3.2 By Therapy Type
  • 9.3.3 By Mode Of Administration
  • 9.3.4 By Application
  • 9.3.5 By Distribution Channel
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Spain
  • 9.3.11 Russia
  • 9.3.12 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Animal Type
  • 9.4.2 By Therapy Type
  • 9.4.3 By Mode Of Administration
  • 9.4.4 By Application
  • 9.4.5 By Distribution Channel
  • 9.4.6 China
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 India
  • 9.4.10 Australia
  • 9.4.11 South East Asia
  • 9.4.12 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Animal Type
  • 9.5.2 By Therapy Type
  • 9.5.3 By Mode Of Administration
  • 9.5.4 By Application
  • 9.5.5 By Distribution Channel
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Animal Type
  • 9.6.2 By Therapy Type
  • 9.6.3 By Mode Of Administration
  • 9.6.4 By Application
  • 9.6.5 By Distribution Channel
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY ONCOLOGY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Zoetis
  • 11.2.2 Boehringer Ingelheim Animal Health
  • 11.2.3 Elanco Animal Health
  • 11.2.4 Merck Animal Health
  • 11.2.5 Virbac
  • 11.2.6 Dechra Pharmaceuticals
  • 11.2.7 Ceva Sante Animale
  • 11.2.8 IDEXX Laboratories
  • 11.2.9 Antech Diagnostics
  • 11.2.10 PetCure Oncology
  • 11.2.11 Ethos Veterinary Health
  • 11.2.12 BluePearl Pet Hospital
  • 11.2.13 Mars Veterinary Health
  • 11.2.14 Animal Oncology And Imaging Center
  • 11.2.15 Varian
  • 11.2.16 Accuray
  • 11.2.17 Elekta
  • 11.2.18 VetDC
  • 11.2.19 Anivive Lifesciences
  • 11.2.20 One Health Group